logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Mirus Bio Corporation


USPTO Granted Patents = 40

% Expired Patents = 50.0


Trademarks = 14

Forward Citations = 356

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Jon Asher Wolff (31 out of 97 patents)

silverMedal Vladimir G Budker (27 out of 59 patents)

bronzeMedal James E Hagstrom (26 out of 64 patents)

4.  Sean D Monahan (17 out of 44 patents)

5.  David B Rozema (13 out of 83 patents)

6.  Paul Michael Slattum (13 out of 26 patents)

7.  Vladimir S Trubetskoy (12 out of 33 patents)

8.  Hans Herweijer (6 out of 12 patents)

9.  Darren H Wakefield (4 out of 58 patents)

10.  Julia Hegge (4 out of 9 patents)

11.  So Wong (3 out of 19 patents)

12.  Nicholas A A Rossi (3 out of 6 patents)

13.  Alexander V Sokoloff (3 out of 5 patents)

14.  Aaron G Loomis (3 out of 3 patents)

15.  David L Lewis (2 out of 44 patents)


Core Competencies:
Transfection Reagents
Nucleic Acid Transfer
Gene Expression
Drug Delivery
Amphipathic Compounds
Polycations
siRNA
Polyampholytes
Intravascular Delivery
Polynucleotide Complex
Target Molecules
Labile Linkage

40 patents:

1. 11739174 - Cationic cyclic amine and amphipathic transfection reagents (2023-08-29),
2. 10619162 - Cationic cyclic amine and amphipathic transfection reagents (2020-04-14),
3. 9677077 - Cationic acrylamide copolymer transfection reagents (2017-06-13),
4. 8921448 - Transfection compositions using amphipathic compounds (2014-12-30),
5. 8129509 - Method for single-step attachment of a label to target molecules (2012-03-06),
6. 7601367 - Compositions and processes using siRNA, amphipathic compounds and polycations (2009-10-13),
7. 7491538 - Gene expression with covalently modified polynucleotides (2009-02-17),
8. 7476401 - Protein and peptide delivery to mammalian cells in vitro (2009-01-13),
9. 7439051 - Process for utilizing epitopes recognized by natural antibodies (2008-10-21),
10. 7435723 - Process for delivery of polynucleotides to the prostate (2008-10-14),
11. 7396919 - Charge reversal of polyion complexes (2008-07-08),
12. 7348453 - Labile linkage for compound delivery to a cell (2008-03-25),
13. 7326780 - Compounds and processes for single-pot attachment of a label to nucleic acid (2008-02-05),
14. 7262056 - Enhancing intermolecular integration of nucleic acids using integrator complexes (2007-08-28),
15. 7220400 - Compositions for delivering nucleic acids to cells (2007-05-22),
Mirus Bio Corporation, based in Madison, WI, specializes in the development and manufacturing of innovative transfection reagents and delivery systems for nucleic acids. The company focuses on enhancing gene expression and facilitating the effective delivery of polynucleotides through its proprietary amphipathic compounds and polyampholytes. Mirus Bio's technologies are pivotal in advancing research and therapeutic applications in gene therapy and drug delivery, addressing critical needs in the life sciences sector.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Mirus Bio Corporation
40 Patents

#23 in Madison, WI

#217 in Wisconsin

#8,618 in US

#17,048 in the World

Madison, WI (US)
Madison, WI, United States of America

Mirus Bio Corporation

Forward Citations = 356

31 inventors:

goldMedal Jon Asher Wolff (31 out of 97 patents)

silverMedal Vladimir G Budker (27 out of 59 patents)

bronzeMedal James E Hagstrom (26 out of 64 patents)

4.  Sean D Monahan (17 out of 44 patents)

5.  David B Rozema (13 out of 83 patents)

Please report any incorrect information to [email protected]
Loading…